Abstract
Mass spectrometric profiling using ProteinChip and magnetic beads has rapidly grown over the past years, particularly to generate serum profiles for cancer diagnosis. The molecular weights of these distinguishing peaks are usually under 30 kDa. To identify those low molecular weight proteins and peptides is important for specific assays to be developed and increases biological insight. In this study, low molecular weight proteins and peptides from serum were purified by a combination of weak cation exchange magnetic beads and high performance liquid chromatography. The purified proteins and peptides were analyzed by 1D SDS PAGE, SELDI and LC-MS/MS. 246 proteins were identified from the HPLC fractions by LC-MS/MS. 95(38.62%) proteins were first identified in serum compare with Sys-BodyFluid database. 11(11/96) proteins were documented cancer associated proteins. We also observed about 109 proteins/peptides in SELDI mass spectrum, and 13 of the SELDI features were identified.
Keywords: SELDI-TOF, Serum proteomics, Weak cation exchange, Mass spectrometry, human serum retentate, HPLC, MB-WCX, TFA, Serum Samples, SDS-PAGE, EAM solution, LC-MS/MS, Sys-BodyFluid, HUPO plasmaSELDI-TOF, Serum proteomics, Weak cation exchange, Mass spectrometry, human serum retentate, HPLC, MB-WCX, TFA, Serum Samples, SDS-PAGE, EAM solution, LC-MS/MS, Sys-BodyFluid, HUPO plasma
Protein & Peptide Letters
Title: Comprehensive Profiling of the Low Molecular Weight Proteins and Peptides in Weak Cation Exchange Beads Human Serum Retentate
Volume: 18 Issue: 5
Author(s): Zhi-Guo Zheng, Hai-Qiang Yu, Zhi-Qiang Ling, Han-Zhou Mou, Hai-Teng Deng and Wei-Min Mao
Affiliation:
Keywords: SELDI-TOF, Serum proteomics, Weak cation exchange, Mass spectrometry, human serum retentate, HPLC, MB-WCX, TFA, Serum Samples, SDS-PAGE, EAM solution, LC-MS/MS, Sys-BodyFluid, HUPO plasmaSELDI-TOF, Serum proteomics, Weak cation exchange, Mass spectrometry, human serum retentate, HPLC, MB-WCX, TFA, Serum Samples, SDS-PAGE, EAM solution, LC-MS/MS, Sys-BodyFluid, HUPO plasma
Abstract: Mass spectrometric profiling using ProteinChip and magnetic beads has rapidly grown over the past years, particularly to generate serum profiles for cancer diagnosis. The molecular weights of these distinguishing peaks are usually under 30 kDa. To identify those low molecular weight proteins and peptides is important for specific assays to be developed and increases biological insight. In this study, low molecular weight proteins and peptides from serum were purified by a combination of weak cation exchange magnetic beads and high performance liquid chromatography. The purified proteins and peptides were analyzed by 1D SDS PAGE, SELDI and LC-MS/MS. 246 proteins were identified from the HPLC fractions by LC-MS/MS. 95(38.62%) proteins were first identified in serum compare with Sys-BodyFluid database. 11(11/96) proteins were documented cancer associated proteins. We also observed about 109 proteins/peptides in SELDI mass spectrum, and 13 of the SELDI features were identified.
Export Options
About this article
Cite this article as:
Zheng Zhi-Guo, Yu Hai-Qiang, Ling Zhi-Qiang, Mou Han-Zhou, Deng Hai-Teng and Mao Wei-Min, Comprehensive Profiling of the Low Molecular Weight Proteins and Peptides in Weak Cation Exchange Beads Human Serum Retentate, Protein & Peptide Letters 2011; 18 (5) . https://dx.doi.org/10.2174/092986611794927983
DOI https://dx.doi.org/10.2174/092986611794927983 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Surgical Treatment in FIGO Stage I Cervical Cancer: Evolution of Concepts
Current Women`s Health Reviews Head and Neck Cancer Treatments through Chemotherapy to Magnetic Systems: Perspectives and Challenges
Current Radiopharmaceuticals The Novel RARβ Isoform (β 5) is a Potential Target of Retinoids in Breast Cancer
Current Cancer Drug Targets Recent Advances in Pharmacokinetics of Polymeric Excipients Used in Nanosized Anti-Cancer Drugs
Current Drug Metabolism Gene Therapy for the Peripheral Nervous System: A Strategy to Repair the Injured Nerve?
Current Gene Therapy Synthesis and Cytotoxic Properties of Halogen and Aryl-/Heteroarylpiperazinyl Derivatives of Benzofurans
Anti-Cancer Agents in Medicinal Chemistry Revealing Insights into Natural Products Against mcr-1-Producing Bacteria
Current Drug Targets Humans Entrain to Sunlight - Impact of Social Jet Lag on Disease and Implications for Critical Illness
Current Pharmaceutical Design Topoisomerase I-DNA Complex Stability Induced by Camptothecins and Its Role in Drug Activity&#
Current Medicinal Chemistry - Anti-Cancer Agents Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Diffuse Large B-Cell Lymphoma with Involvement of the Chest Wall
Current Respiratory Medicine Reviews Regulation of Glycolytic and Mitochondrial Metabolism by Ras
Current Pharmaceutical Biotechnology Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment
Current Drug Targets Meet Our Editorial Board Member:
Current Medicinal Chemistry High Throughput Study for Molecular Mechanism of Metformin Pre-Diabetic Protection <i>via</i> Microarray Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options
Current Medicinal Chemistry Mechanisms of the Penetration of Blood-Borne Substances into the Brain
Current Neuropharmacology Carbohydrates: Potential Sweet Tools Against Cancer
Current Medicinal Chemistry Role of Inflammatory Mediators in Angiogenesis
Current Drug Targets - Inflammation & Allergy Can Breast Cancer Stem Cells Evade the Immune System?
Current Medicinal Chemistry